A not-for-profit community journal that reviews the most important advances in the clinical management of HIV and access to treatment.
Introduction to HIV pipeline 2017
Latest review of future HIV drugs: and what to watch for at IAS 2017 in Paris
Unexpected side effects with generic abacavir – and potential for rare reactions to other generic ARVs
Potential side effects with generic abacavir
Editor: Simon Collins. Contributing editor: Polly Clayden. ISSN 1472-4863.
Subscriptions are free — by post, email and online.
Each issue of HTB is circulated for comments to our medical review board.
- July/August 2017: Volume 18 Number 7/8 14 August 2017.
- HIV Pipeline Report (2017) 14 August 2017.
- Fit for Purpose: HIV treatment optimisation for adults and children (2017) 14 August 2017.
- i-Base 2017 appeal: we need your help…. 10 August 2017.
- 9th IAS Conference on HIV Science (IAS 2017) 10 August 2017.
- HIV pipeline drugs: IAS 2017 update 10 August 2017.
- Darunavir/cobicistat/FTC/TAF: 24-week interim results from phase 3 switch study 10 August 2017.
- Phase 3 results with bictegravir FDC: a new integrase inhibitor combined with FTC/TAF 10 August 2017.
- Doravirine/3TC/TDF compared to efavirenz/FTC/TDF as first-line ART 10 August 2017.
- Continued viral suppression with long-acting cabotegravir/rilpivirine injections: 96-week LATTE-2 results 10 August 2017.
- Reduced-dose darunavir is safe and effective in switch study 10 August 2017.
- MK-8591: further compelling early results for both treatment and prevention 10 August 2017.
- Dolutegravir outperforms lopinavir/ritonavir second-line: interim results from the DAWNING study 10 August 2017.
- Preliminary results on dolutegravir use in pregnancy are reassuring 10 August 2017.
- Low dose efavirenz (EFV400) can be used during pregnancy 10 August 2017.
- Stillbirth rate in HIV positive women in UK/Ireland is double that of the general population 10 August 2017.
- Swaziland nearly halves HIV incidence in five years 10 August 2017.
- Gay men with undetectable viral load do not transmit HIV: Opposites Attract study supports U=U 10 August 2017.
- HIV remission news from IAS 2017 10 August 2017.
- Publications launched at IAS 2017 10 August 2017.